Cargando…
Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk – A Systematic Review and Meta-Analysis
BACKGROUND: Pneumococcal community-acquired pneumonia (pCAP) is the most frequent form of pneumonia. The elderly and adults with underlying diseases are at an increased risk of developing pCAP. The 23-valent pneumococcal polysaccharide vaccine (PPV23) was licensed over 30 years ago and is recommende...
Autores principales: | Schiffner-Rohe, Julia, Witt, Annika, Hemmerling, Jana, von Eiff, Christof, Leverkus, Friedrich-Wilhelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711910/ https://www.ncbi.nlm.nih.gov/pubmed/26761816 http://dx.doi.org/10.1371/journal.pone.0146338 |
Ejemplares similares
-
Population-based incidence and mortality of community-acquired pneumonia in Germany
por: Theilacker, Christian, et al.
Publicado: (2021) -
Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time
por: Sprenger, Ralf, et al.
Publicado: (2022) -
Pneumococcal vaccination rates in immunocompromised patients—A cohort study based on claims data from more than 200,000 patients in Germany
por: Schmedt, Niklas, et al.
Publicado: (2019) -
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
por: Falkenhorst, Gerhard, et al.
Publicado: (2017) -
Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs
por: Horn, Matthias, et al.
Publicado: (2023)